cyclosporine has been researched along with Hematoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acar, H; Fazliogullari, Z; Karabulut, AK; Unver Dogan, N; Uysal, II | 1 |
Ichinose, A; Ieko, M; Inoue, M; Kasahara, Y; Kurita, T; Majima, T; Matsuoka, M; Onodera, T; Souri, M; Takahashi, D | 1 |
2 other study(ies) available for cyclosporine and Hematoma
Article | Year |
---|---|
Investigation of developmental toxicity and teratogenicity of cyclosporine A, tacrolimus and their combinations with prednisolone.
Topics: Abnormalities, Drug-Induced; Animals; Apoptosis; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Embryo Culture Techniques; Embryo, Mammalian; Female; Gestational Age; Hematoma; Humans; Immunosuppressive Agents; Neural Tube Defects; Prednisolone; Pregnancy; Rats, Wistar; Risk Assessment; Tacrolimus; Teratogens; Toxicity Tests | 2016 |
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
Topics: Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Cyclosporine; Down-Regulation; Factor XIII; Factor XIII Deficiency; Fibrinogen; Hematoma; Humans; Immunosuppressive Agents; Interleukin-6; Male; Methotrexate; Methylprednisolone; Middle Aged; Postoperative Complications; Sjogren's Syndrome | 2012 |